Markets:

Overview

News

Currencies

International

Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

6.155 +0.115 (+1.90%)

Delayed Quote Updated: 11:45 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precigen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 07, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Recap: Precigen Q4 Earnings ↗

March 01, 2022

Precigen (NASDAQ:PGEN) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 14, 2022

During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

PRECIGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Precigen, Inc. f/k/a Intrexon Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

March 28, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

March 16, 2022

On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Looking Into Precigen's Return On Capital Employed ↗

March 04, 2022

According to data from Benzinga Pro, during Q4, Precigen's (NASDAQ:PGEN) reported sales totaled $24.22 million. Despite a 15.89% increase in earnings, the company posted a loss of...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 18, 2022

On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...

Via Benzinga

3 Synthetic Biology Stocks In Focus With Strong Potential ↗

December 26, 2021

Here we discuss three stocks engaged in the field of scientific biology that investors must follow, as they have the potential to generate wealth going forward.

Via Talk Markets

Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients ↗

December 14, 2021

Precigen Inc (NASDAQ: PGEN) presented positive interim data at the ASH Annual Meeting and Exposition from the ongoing Phase 1/1b study of PRGN-3006 UltraCAR-T in...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

December 01, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 24, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Via Benzinga

Precigen Posts Additional Interim Data From Type 1 Diabetes Trial ↗

October 01, 2021

Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio has announced additional interim data from Phase 1b/2a study of AG019 ActoBiotics for...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Precigen Earnings Perspective: Return On Capital Employed ↗

September 17, 2021

According to data from Benzinga Pro, during Q2, Precigen's (NASDAQ:PGEN) reported sales totaled $33.58 million. Despite a 11.39% increase in earnings, the company posted a loss of...

Via Benzinga

Precigen, inc (PGEN) Q2 2021 Earnings Call Transcript ↗

August 09, 2021

PGEN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Precigen: Q2 Earnings Insights ↗

August 09, 2021

Shares of Precigen (NASDAQ:PGEN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 61.54% year over year to...

Via Benzinga

Precigen Insights: Return On Capital Employed ↗

June 25, 2021

During Q1, Precigen (NASDAQ:PGEN) brought in sales totaling $24.51 million. However, earnings decreased 598.82%, resulting in a loss of $17.69 million. Precigen reached earnings...

Via Benzinga

46 Stocks Moving In Friday's Mid-Day Session ↗

June 11, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...

Via Benzinga

Topics Initial Public Offering

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 11, 2021

Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 11, 2021

Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...

Via Benzinga

Precigen Stock Surges On Positive AG019 Data for Chronic Treatment Of Type 1 Diabetes ↗

June 11, 2021

Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio announced topline results from the Phase 1b/2a study evaluating AG019 ActoBiotics to treat recent-...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.